Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion

Dementia and Geriatric Cognitive Disorders

Volumn 39, Issue 5-6, 2015, Pages 287-293

  Kämälaïnen, Anna ^a   Herukka, Sanna Kaisa ^a   Hartikainen, Païvi ^a   Helisalmi, Seppo ^a   Moilanen, Virpi ^b   Knuuttila, Anna ^c   Jansson, Lilja ^c   Tienari, Pentti J ^c   Remes, Anne M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alzheimer's disease; Biomarkers; C9ORF72; Cerebrospinal fluid; Frontotemporal lobar degeneration; Motor neuron disease; Non Alzheimer's dementia; TDP 43

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN; APOLIPOPROTEIN 3; APOLIPOPROTEIN E4; CHROMOSOME 9 OPEN READING FRAME 72; CHROMOSOME PROTEIN; PHOSPHO TAU PROTEIN; TAU PROTEIN; TOTAL TAU PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; C9ORF72 PROTEIN, HUMAN; DNA BINDING PROTEIN; PROTEIN; PROTEIN TDP-43; REPETITIVE DNA;

ADULT; ALLELE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; AGED; BRAIN; COHORT ANALYSIS; GENETICS; ONSET AGE; PATHOLOGY;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BRAIN; COHORT STUDIES; DNA REPEAT EXPANSION; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; PROTEINS; TAU PROTEINS;

EID: 84925436703     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000371704     Document Type: Article

References (35)

1. Ikeda M, Ishikawa T, Tanabe H: Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004; 17: 265-268.
2. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
3. Majounie E, Renton AE, Mok K, et al: Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012; 11: 323-330.
4. Renton AE, Majounie E, Waite A, et al: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-268.
5. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-256.
6. Velakoulis D, Walterfrang M, Mocellin R, Pantelis C, McLean C: Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry 2009; 194: 298-305.
7. Wallon D, Rovelet-Lecrux A, Deramecourt V, Pariente J, Auriacombe S, Le Ber I, Schraen S, Pasquier F, Campion D, Hannequin D: Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. J Alzheimers Dis2012; 32: 19-22.
8. Herukka SK, Hallikainen M, Soininen H, Pirttilä T: CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. Neurology 2005; 64: 1294-1297.
9. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009; 302: 385-393.
10. Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T: Cerebrospinal fluid betaamyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 2009; 66: 382-389.
11. Zetterberg H, Lunn MP, Herukka SK: Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease. Biomark Med 2012; 6: 371-376.
12. Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M: CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 2008; 70: 1827-1835.
13. Cacace R, Van Cauwenberghe C, Bettens K, Gijsenlinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Baümer V, Dillen L, Mattheijssens M, Peeters K, Cruts M, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K: C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2013; 34: 1712.e1-e7.
14. Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM: Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005; 57: 721-729.
15. Hu W.T, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ: Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology 2010; 75: 2079.
16. Irwin DJ, Trojanowski JQ, Grossman M: Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease. Front Aging Neurosci 2013; 5: 6.
17. Shinagawa S, Naasan G, Coppola G, Pribadi M, Seeley WW, Trojanowski JQ, Miller BL, Grinberg LT: Clinicopathological study of patients with C9ORF72-associated frontotemporal dementia presenting with delusions. J Geriatr Psychiatry Neurol 2014, Epub ahead of print.
18. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, Duplessis D, Neary D, Mann DM, Pickering-Brown SM: Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012; 135: 693-708.
19. Ben-Avi L, Durst R, Shpitzen S, Leitersdorf E, Meiner V: Apolipoprotein E genotyping: accurate, simple, high throughput method using ABI Prism SNaPshot Multiplex system. J Alzheimers Dis 2004; 6: 497-501.
20. Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK: Longitudinal changes of CSF biomarkers in Alzheimer's disease. J Alzheimers Dis 2011; 25: 583-594.
21. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW: Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 2011; 122: 673-690.
22. Mahouney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD: Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012; 135: 736-750.
23. Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S, Ferrer I, Gelpi E, Kövari V, Kretzschmar H, Nagy Z, Parchi P, Seilhean D, Soininen H, Troakes C, Budka H: Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 2008; 26: 343-350.
24. Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, Lace G, Ince PG; Medical Research Council Cognitive Function and Aging Study: Epidemiological neuropathology: the MRC cognitive function and aging study experience. J Alzheimers Dis 2011; 25: 359-372.
25. Bieniek KF, Murray M, Rutherford N, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW: Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathol 2013; 125: 289-302.
26. King A, Al-Sarraj S, Troakes C, Smith B, Maekawa S, Iovino M, Spillantini MG, Shaw CE: Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta Neuropathol 2013; 125: 303-310.
27. Krüger J, Kaivorinne AL, Udd B, Majamaa K, Remes AM: Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol 2009; 16: 27-30.
28. Krüger J, Moilanen V, Majamaa K, Remes AM: Molecular genetic analysis of the APP, PSEN1 and PSEN2 genes in Finnish patients with early-onset Alzheimer's disease and frontotemporal dementia. Alzheimer Dis Assoc Disord 2012; 26: 272-276.
29. Kaivorinne AL, Krüger J, Kuivaniemi K, Tuominen H, Moilanen V, Majamaa K, Remes AM: Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol 2008; 8: 48.
30. Kaivorinne AL, Moilanen V, Kervinen M, Renton AE, Traynor BJ. Majamaa K, Remes AM: Novel TARDBP sequence variant and C9ORF72 repeat expansion in a family with frontotemporal dementia. Alzheimer Dis Assoc Disord 2014; 28: 190-193.
31. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, Holtzman DM: Decreased cerebrospinal fluid A42 correlates with brain atrophy in cognitively normal elderly. Ann Neurol 2009; 65: 176-183.
32. Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM: Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 2012; 78: 47-54.
33. Jellinger K, Attems J: Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 2010; 119: 421-433.
34. Neuropathology Group, Medical Research Council Cognitive Function and Aging Study: Pathological correlates of late-onset dementia in multicentre, community-based population in English and Wales. Lancet 2001; 357: 169-175.
35. Sjögren M, Vanderstichele H, Agren Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K: Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 2001; 47: 1776-1781.